Dermatitis, Atopic: all 1,443 studies

Page 6 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT02087943Phase 2Results posted
• A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic DermatitisCompletedNCT02068352Phase 2Results posted
• Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic DermatitisCompletedNCT02004041Phase 2Results posted
• Effect of OC000459 on Moderate to Severe Atopic DermatitisCompletedNCT02002208Phase 2Results posted
• Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)CompletedNCT02001181Phase 2Results posted
• Photocil (Topical) for the Treatment of Atopic DermatitisCompletedNCT01992172Not applicableResults posted
• A Phase 2 Study of CIM331 for Atopic Dermatitis PatientsCompletedNCT01986933Phase 2Results posted
• Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)CompletedNCT01979016Phase 2Results posted
• Validation of the Short-term Antimicrobial Action of Transplanted BacteriaCompletedNCT01959113Phase 1Results posted
• Open-label Study of Dupilumab in Patients With Atopic DermatitisCompletedNCT01949311Phase 3Results posted
• A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic DermatitisCompletedNCT01945086Phase 2Results posted
• Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic DermatitisCompletedNCT01941537Phase 2Results posted
• A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic DermatitisCompletedNCT01915914Phase 4Results posted
• Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated PruritusCompletedNCT01905631Phase 2Results posted
• Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT01859988Phase 2Results posted
• Topical Roflumilast in Adults With Atopic DermatitisCompletedNCT01856764Phase 2Results posted
• Pilot Study of Ustekinumab for Subjects With Chronic Atopic DermatitisCompletedNCT01806662Phase 2Results posted
• Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.CompletedNCT01785602Phase 2Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic DermatitisCompletedNCT01756898Phase 2Results posted
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyCompletedNCT01737710Not applicableResults posted
• A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)TerminatedNCT01732510Phase 1Results posted
• Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic DermatitisCompletedNCT01652885Phase 1/2Results posted
• Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT01639040Phase 2Results posted
• Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic DermatitisCompletedNCT01602341Phase 2Results posted
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic DermatitisTerminatedNCT01577628Not applicableResults posted
• Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic DermatitisCompletedNCT01548404Phase 2Results posted
• A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLCompletedNCT01544348Phase 1Results posted
• Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic DermatitisCompletedNCT01469767Phase 2Results posted
• Apremilast for Atopic Dermatitis - A Pilot Study in AdultsCompletedNCT01393158Phase 2Results posted
• Comparing Cetaphil Restoraderm System Versus Standard Skin Care in InfantsCompletedNCT01375205Not applicableResults posted
• Vitamin D Deficiency and Atopic DermatitisTerminatedNCT01337635Not applicableResults posted
• Human Testing of an Over-the-Counter (OTC) Cream in Children With EczemaCompletedNCT01326910Not applicableResults posted
• Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic DermatitisCompletedNCT01301508Phase 2Results posted
• A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a PlaceboCompletedNCT01299610Phase 2Results posted
• Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine TherapyCompletedNCT01149759Not applicableResults posted
• Study of 0417 Ointment in the Treatment of Atopic DermatitisCompletedNCT01139450Phase 3Results posted
• Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult PopulationCompletedNCT01137032Phase 4Results posted
• Cooling Pillow for Atopic DermatitisCompletedNCT01132651Not applicableResults posted
• Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic DermatitisCompletedNCT01093469Phase 4Results posted
• Acupressure in Pruritus for Atopic DermatitisCompletedNCT01074164Not applicableResults posted
• A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic DermatitisCompletedNCT01065714Phase 4Results posted
• Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic DermatitisCompletedNCT01064947Phase 4Results posted
• Study of 0416 Ointment in the Treatment of Atopic DermatitisCompletedNCT01053247Phase 3Results posted
• A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic DermatitisCompletedNCT01049243Phase 4Results posted
• LEO 29102 Cream in the Treatment of Atopic DermatitisCompletedNCT01037881Phase 2Results posted
• Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American PopulationCompletedNCT01016106Not applicableResults posted
• Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With EczemaCompletedNCT00946478Not applicableResults posted
• Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic DermatitisTerminatedNCT00931411Not applicableResults posted
• Study of Apremilast in Atopic or Contact DermatitisCompletedNCT00931242Phase 2Results posted
• Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic DermatitisCompletedNCT00919763Phase 2Results posted
• Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)CompletedNCT00914186Phase 2Results posted
• The Effectiveness of Montelukast on Atopic Dermatitis in KoreansCompletedNCT00903357Not applicableResults posted
• To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in ChildrenCompletedNCT00886587Not applicableResults posted
• Management of Pruritus With Xyzal in Atopic DermatitisCompletedNCT00884325Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT00832585Phase 4Results posted
• Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic DermatitisCompletedNCT00828412Phase 4Results posted
• VANOS Cream and Skin Barrier FunctionCompletedNCT00819507Phase 4Results posted
• An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic DermatitisCompletedNCT00806221Phase 2Results posted
• Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3CompletedNCT00789880Phase 2Results posted
• Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic DermatitisCompletedNCT00757042Phase 1Results posted
• Immune Response to Yellow Fever Vaccination in Adults With Atopic DermatitisCompletedNCT00723489Phase 1/2Results posted
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic DermatitisCompletedNCT00717769Phase 2Results posted
• Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic DermatitisCompletedNCT00693693Phase 4Results posted
• Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic DermatitisCompletedNCT00690833Phase 4Results posted
• Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)TerminatedNCT00671528Phase 4Results posted
• Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return VisitCompletedNCT00654355Phase 4Results posted
• Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food AllergensCompletedNCT00557284Phase 4Results posted
• Cutivate Lotion HPA Axis Pediatric StudyCompletedNCT00546000Phase 4Results posted
• An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic DermatitisTerminatedNCT00455429Phase 2Results posted
• A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic DermatitisCompletedNCT00316602Phase 2Results posted
• The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic DermatitisCompletedNCT00179959Phase 4Results posted
• Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)CompletedNCT00152464Phase 3Results posted
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationTerminatedNCT00124709Phase 4Results posted
• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisCompletedNCT00120523Phase 3Results posted
• Combination Therapy for Atopic DermatitisCompletedNCT00119158Phase 4Results posted
• EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLORCompletedNCT07839897Not applicable
• EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITISCompletedNCT07819071Not applicable
• Clinical Trial to Evaluate the Efficacy and Safety of an Ozonated Oil in Atopic DermatitisCompletedNCT07744516Not applicable
• Efficacy Study of a Repairing Cream in Atopic DermatitisCompletedNCT07742241Not applicable
• NPQ Plus Supplementation for Skin Health and Antioxidant StatusCompletedNCT07703215Not applicable
• A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone SkinActive, not recruitingNCT07700745Not applicable
• Topical Chinese Medicine and Exosome Mechanisms for Atopic DermatitisActive, not recruitingNCT07693400Phase 2
• HL-300 Ointment in Healthy VolunteersCompletedNCT07684937Phase 1
• The Effects of an L-histidine-Based Supplement, Eczema Topical, and Unscented Soap on Children With EczemaCompletedNCT07670676Not applicable
• Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic DermatitisCompletedNCT07653386Not applicable
• Dermocosmetic Evaluation of Propolis Ointments in Atopic-Prone Dry SkinCompletedNCT07618234Not applicable
• Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two InterventionsCompletedNCT07599878Not applicable
• Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)Active, not recruitingNCT07582237
• Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic TreatmentsCompletedNCT07577921
• Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsCompletedNCT07574242Not applicable
• Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.Active, not recruitingNCT07568665
• Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic DermatitisCompletedNCT07537751Not applicable
• A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.CompletedNCT07533851Phase 1
• A Clinical Study to Evaluate SM17 in Healthy ParticipantsCompletedNCT07466940Phase 1
• A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous InjectionCompletedNCT07411755Phase 1
• A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 1
• Methotrexat to Hand Eczema in the BIOSKIN CohortActive, not recruitingNCT07338305
• Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic DermatitisCompletedNCT07336940Phase 1
• Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).CompletedNCT07333300Not applicable
• Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic DermatitisCompletedNCT07329101Phase 1

← Dermatitis, Atopic overview